Featured education and services for you
About RINVOQ
Upadacitinib is an oral medication used to treat a number of immune-mediated inflammatory diseases.
Destination Pharmacy
A pharmacy network supporting patients between medical appointments.
Patient support
Services and tools for your HUMIRA and SKYRIZI patients on their treatment journey.
Stock replacement
Return expired or incorrectly ordered HUMIRA stock.
News and events
Pharmacist CPD education
Learn about the HUMIRA citrate-free formulation, 80 mg presentation and re-designed Pen.
PBS Information
RINVOQ: Authority required. Refer to PBS Schedule for full authority information.
HUMIRA: Authority required. Refer to PBS Schedule for full authority information. This product is not listed on the PBS for the treatment of enthesitis-related arthritis or paediatric psoriasis.
SKYRIZI: Authority required for the treatment of adults with severe plaque psoriasis. SKYRIZI is not listed on the PBS for the treatment of psoriatic arthritis. Refer to PBS Schedule for full authority information.
Please review the full Product Information (PI) before prescribing, available below.
AU-HUM-220152. June 2024